list of glp-1 drugs Drug Comparison in Diabetes and Obesity Treatment Ads for GLP‑1 drugs are

Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) receptor agonists mark a significant breakthrough in diabetes and obesity management, significantly aiding in weight loss and glycemic control

Unimolecular multi-specific agonist peptides targeting multiple incretin pathways have emerged as promising therapeutic strategies for weight loss 7,8,18,19,20,21,22,23,24,25,26

GLP-1RA use was associated with a 28% lower risk of AUD diagnosis (HR = 0.72, 95% CI 0.590.89

Only 0.008% reported subsequent hair regrowth during the study periods

Participants who received the highest dose of orforglipron, 36 milligrams, lost 11.2% of their body weight - about 25 pounds on average - over more than 16 months

Cell Metabol